Robert Frederich

14.0k total citations · 6 hit papers
77 papers, 10.8k citations indexed

About

Robert Frederich is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Robert Frederich has authored 77 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Endocrinology, Diabetes and Metabolism, 41 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Robert Frederich's work include Diabetes Treatment and Management (51 papers), Metabolism, Diabetes, and Cancer (35 papers) and Regulation of Appetite and Obesity (14 papers). Robert Frederich is often cited by papers focused on Diabetes Treatment and Management (51 papers), Metabolism, Diabetes, and Cancer (35 papers) and Regulation of Appetite and Obesity (14 papers). Robert Frederich collaborates with scholars based in United States, Canada and Sweden. Robert Frederich's co-authors include Jeffrey S. Flier, Bradford B. Lowell, A. Hamann, Darren K. McGuire, Elizabeth Konz, James W. Anderson, Constance L. Wood, Stephen Anderson, Boaz Hirshberg and Jaime A. Davidson and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

Robert Frederich

76 papers receiving 10.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

2013 2.5k citations Benjamin M. Scirica, Deepak L. Bhatt et al. profile →
Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action

1995 1.4k citations Robert Frederich, A. Hamann et al. Nature Medicine profile →
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes

2020 1.0k citations Christopher P. Cannon, Richard E. Pratley et al. profile →
Long-term weight-loss maintenance: a meta-analysis of US studies

2001 961 citations James W. Anderson, Elizabeth Konz et al. American Journal of Clinical Nutrition profile →
Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia

1997 657 citations Robert Frederich, Jeffrey S. Flier et al. profile →
Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

2014 545 citations Benjamin M. Scirica, Eugene Braunwald et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Frederich United States	33	5.5k	2.9k	2.9k	2.6k	2.1k	77	10.8k
Christian Weyer United States	44	4.1k 0.7×	5.0k 1.8×	3.7k 1.3×	2.2k 0.8×	4.1k 2.0×	63	12.3k
Niels Møller Denmark	60	6.3k 1.1×	5.8k 2.0×	1.7k 0.6×	2.8k 1.0×	1.6k 0.7×	368	13.1k
Martin Haluzı́k Czechia	53	2.8k 0.5×	3.9k 1.4×	1.4k 0.5×	4.4k 1.7×	3.9k 1.9×	363	12.1k
Erik Näslund Sweden	54	2.1k 0.4×	4.6k 1.6×	2.2k 0.8×	1.9k 0.7×	1.8k 0.9×	214	10.7k
Uberto Pagotto Italy	59	5.2k 0.9×	3.0k 1.1×	2.1k 0.7×	1.8k 0.7×	1.4k 0.7×	269	13.3k
Hanno Pijl Netherlands	60	2.9k 0.5×	3.8k 1.3×	2.3k 0.8×	1.9k 0.7×	1.3k 0.6×	279	10.1k
Hiroaki Masuzaki Japan	56	3.0k 0.5×	5.0k 1.8×	4.6k 1.6×	2.5k 0.9×	3.3k 1.6×	243	12.8k
Alain Baron United States	45	8.0k 1.5×	3.1k 1.1×	1.2k 0.4×	3.8k 1.5×	1.6k 0.8×	70	13.7k
Takao Saruta Japan	64	4.8k 0.9×	3.0k 1.1×	1.1k 0.4×	3.8k 1.4×	1.8k 0.8×	531	15.5k
Dariush Elahi United States	56	5.9k 1.1×	2.8k 1.0×	1.0k 0.4×	2.7k 1.0×	1.1k 0.5×	153	10.7k

Countries citing papers authored by Robert Frederich

Since Specialization

Citations

This map shows the geographic impact of Robert Frederich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Frederich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Frederich more than expected).

Fields of papers citing papers by Robert Frederich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Frederich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Frederich. The network helps show where Robert Frederich may publish in the future.

Co-authorship network of co-authors of Robert Frederich

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Frederich. A scholar is included among the top collaborators of Robert Frederich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Frederich. Robert Frederich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pandey, Ambarish, Ahmed A. Kolkailah, Robert Frederich, et al.. (2025). Heart Failure Outcomes Captured by Adverse Event Reporting in Participants with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Observations from the VERTIS CV Trial. European Journal of Heart Failure. 27(3). 521–526. 1 indexed citations

Dagogo‐Jack, Samuel, Robert Frederich, Jie Liu, et al.. (2023). Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV. The Journal of Clinical Endocrinology & Metabolism. 108(8). 2042–2051. 2 indexed citations

Cherney, David Z.I., Francesco Cosentino, Darren K. McGuire, et al.. (2023). Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV) Trial. Kidney International Reports. 8(4). 746–753. 1 indexed citations

Cherney, David Z.I., Samuel Dagogo‐Jack, Francesco Cosentino, et al.. (2022). Heart and Kidney Outcomes With Ertugliflozin in People with Non-albuminuric Diabetic Kidney Disease: A post hoc Analysis from the Randomized VERTIS CV Trial. Kidney International Reports. 7(8). 1782–1792. 5 indexed citations

Cosentino, Francesco, Christopher P. Cannon, David Z.I. Cherney, et al.. (2020). Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease. Circulation. 142(23). 2205–2215. 175 indexed citations

Cherney, David Z.I., Hiddo J.L. Heerspink, Robert Frederich, et al.. (2020). Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials. Diabetologia. 63(6). 1128–1140. 33 indexed citations

Leiter, Lawrence A., Hwee Teoh, Eugene Braunwald, et al.. (2015). Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial. Diabetes Care. 38(6). 1145–1153. 74 indexed citations

Buzzetti, Raffaella, Paolo Pozzilli, Robert Frederich, N Iqbal, & Boaz Hirshberg. (2015). Saxagliptin improves glycaemic control and C‐peptide secretion in latent autoimmune diabetes in adults (LADA). Diabetes/Metabolism Research and Reviews. 32(3). 289–296. 46 indexed citations

Cobble, Michael E. & Robert Frederich. (2012). Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data. Cardiovascular Diabetology. 11(1). 6–6. 66 indexed citations

10.

Pfützner, Andreas, et al.. (2011). Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks. Diabetes Obesity and Metabolism. 13(6). 567–576. 82 indexed citations

11.

Frederich, Robert, John H. Alexander, Fred T. Fiedorek, et al.. (2010). A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes. Postgraduate Medicine. 122(3). 16–27. 182 indexed citations

12.

Frederich, Robert, Mark Donovan, Niklas Berglind, et al.. (2009). Abstract 978: Cardiovascular Safety of Saxagliptin as Mono- or Add-on Therapy in Patients With Type 2 Diabetes. Circulation. 120. 2 indexed citations

13.

Houseknecht, Karen L., Sarah N. Flier, Ernst U. Frevert, et al.. (2009). O-2: Leptin secretion by the adipocyte: Regulation with genetic and dietary obesity and search for an intracellular storage pool. Experimental and Clinical Endocrinology & Diabetes. 104(S 02). 8–8. 2 indexed citations

14.

Rush, Craig R., et al.. (2007). Behavioral and subjective effects of D-amphetamine and modafinil in healthy adults.. Experimental and Clinical Psychopharmacology. 15(2). 123–133. 52 indexed citations

15.

Frederich, Robert, et al.. (2002). Leptin in anorexia nervosa and bulimia nervosa: Importance of assay technique and method of interpretation. Journal of Laboratory and Clinical Medicine. 139(2). 72–79. 16 indexed citations

16.

Gaetke, Lisa M., Helieh S. Oz, Willem J.S. de Villiers, Gary W. Varilek, & Robert Frederich. (2002). The Leptin Defense against Wasting Is Abolished in the IL-2–Deficient Mouse Model of Inflammatory Bowel Disease. Journal of Nutrition. 132(5). 893–896. 17 indexed citations

17.

Anderson, James W., Elizabeth Konz, Robert Frederich, & Constance L. Wood. (2001). Long-term weight-loss maintenance: a meta-analysis of US studies. American Journal of Clinical Nutrition. 74(5). 579–584. 961 indexed citations breakdown →

18.

Zhang, Bei, Michael P. Graziano, Thomas W. Doebber, et al.. (1996). Down-regulation of the Expression of the Obese Gene by an Antidiabetic Thiazolidinedione in Zucker Diabetic Fatty Rats and db/db Mice. Journal of Biological Chemistry. 271(16). 9455–9459. 161 indexed citations

19.

Frederich, Robert, et al.. (1995). Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nature Medicine. 1(12). 1311–1314. 1368 indexed citations breakdown →

20.

Frederich, Robert, Barbara B. Kahn, M J Peach, & Jeffrey S. Flier. (1992). Tissue-specific nutritional regulation of angiotensinogen in adipose tissue.. Hypertension. 19(4). 339–344. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact